Last updated on August 2018

A Multicenter, Fixed-Dose, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of AR19 (Amphetamine Sulfate) in Adult Subjects (Ages 18-55) with Attention Deficit Hyperactivity Disorder (ADHD)

Brief description of study

A study of an adult ADHD medication for men and women 18 to 55 years of age.


Clinical Study Identifier: TX210955

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

Meridien Research - Lakeland
Lakeland, FL United States
  Connect »